All In Biotech

Drug Trial Radar · NCT00162370

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

SMART: Stress Echocardiography in Menopausal Women at Risk for Coronary Artery Disease Trial

Last checked: Nov 19, 2026Latest source record: Mar 15, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

400

Actual

Start

Apr 2004

Primary completion

Sep 2012

Study completion Oct 2012

Sponsor

Lead sponsor
Lantheus Medical ImagingIndustry
Sponsor type
Industry
First posted
Sep 13, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
Female only, from 40 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.

Conditions

  • Coronary Artery Disease
  • Heart Disease

Interventions

  • Perflutren Lipid Microsphere Injectable SuspensionDrug

    Activated DEFINITY 10ug/kg by bolus injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Abnormal Contrast Stress Echocardiography and With Future Major Adverse Cardiac Events (MACE) at 2 and 5 Years Follow-UpTime frame: 2 year and 5 year follow up

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Local Institution

    Scottsdale, Arizona

  • Local Institution

    Jacksonville, Florida

  • Local Institution

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.